The true conviction of Paradigm's $4 ( albeit CAD ) target!Well, upon close review of trading and an even closer review of true intentions, it's going to get interesting next week when it comes to share price direction, buyers and sellers.
Based on the "uncertainty" or any real promotion or actual news flow here to the US, I'm most curious to learn what is in store for next week and the following 2 weeks of TAX LOSS time.
Paradigm last bought 5,000 shares or about $2,500 CAD worth of stock on September 1st at 53 pennies CAD....hmmmm?? Since that time they've updated or "re-iterated" their BUY target at $4 CAD and placed their PHD at the wheel, so to speak. As a long time holder and person that recognizes ALL the "players" and their role in this "mystery wrapped in a twinkie", I'm more excited than ever and believe the 11 mystery institutional players to be essentially, "more partners" They are playing EXACTLY as local rules have been laid out. Remember, how might 9 MILLION shares have been aquired at "market"? IMPOSSIBLE! I suppose those that bought at 60 cents CAD are likely disappointed with the FDA approval of DIMI that took nearly 2 WHOLE months to come after they bought at the positioned 60 cent CAD offering...no wonder the price dropped on the FDA approval announcement ; - )
Stay tuned, does house 16 ( Paradigm ) return to the BUY button Monday and quite frankly, follow the "under valued" assessment for the limited existing holders that listened to the 2 hours of educated uncertainty? I think not, I believe the paper is far too valuable, I see further reduction in the SP and potentially a filling of the 1M shares "bid nested" at 30 cents CAD ( good hands peeps waiting to take the struggling papier ) If only someone(s) knew this story inside out and had access to significant amounts of wealth. Now would be the time to buy like there is no tomorrow ( IMHO ) Buying when weakness and uncertainty prevailed, when only 3 stray patients were added to our TIGRIS ( should have been explained fellas, confirmatory, 2 to 1 ratio, Debra and River's knew post-hoc analysis on reduction in endotoxin better than the mean etc... ) We're not that obtuse "friend", maybe a sprinkling of important science in the 2 hour production would have been a good thing. Afterall, 4 years later none of the really good "post-hoc analysis" has been shared with conviction or at least in a way the October 3rd 2016 news was. I think an absolute benefit of 17% as discovered by our two brilliant scientific shareholders would be fare to share with all of your loyal holders! What is this multi-filter Italian expedition and why aren't we aware of it, another smashing Euphas phase 2 success? One that EDT is "left out" of? Why is our name only acceptable in Canada, and if so, why isn't our treatment good enough for Canadiens, the majority of our shareholders and people important to them?
Next week will be interesting and as transparent as the 108 puzzle pieces that iced our Baxter welcome cake. I guess after awhile things become the norm, but the explanation on the lack of usage up in Canada for the fully approved PMX theranostic was perhaps the "loest point" in my many years of holding this stock. My intention is to write an email to Spectral's chair, Baxter and the Canada Health asking them why 35 million Canadiens are inferior to 360M Yanks? Toray's mission statement is noble, the full approval in Canada ( since 2009 ) and the lack of deployment during a pendemic is troubling, how can Toray justify? If you can't find anyone to treat in Canada, you should pack up shop and move on to a LSD phase 1 trial like Mindmed ( MMED ) Yesterday their company value rose by 110M CAD..on nothing, in one day..surpassing the total value of EDT in just one day of trading. Spectral is now valued at 90M CAD, and MMED at 900M million CAD ( phase 1 LSD / ACID trial ) If EDT or EDTXF trading "sucks next week", and I think it will, back up the truck and understand what it is that is going on. Sad but true, it's what happens when two brilliant docs invent something the money people need to exploit. Tributaries continue to form on the banks of the rising TIGRIS, with each new vehicle comes the dream of alluvial gold, even if short lived, why not let a true game changer in critical care medicine make many, many people wealthier for the effort.
ALWAYS do your own homework and do consult a licenced professional when matters of >$100 CAD or > $50 USD are involved. BULLboards are not the place to make investment decisions, BUT certainly a place to judge the quality of a "character" and their true intentions" ; - ) NOTHING burger, or a burger with so much meat, it must be shared only when the important company visits?
Tom
Ps - too bad we are once again "late to the treatment party" as it pertains to CV19, didn't we learn from the phase 3? Sounds like the Europeans did? What is the name of this 50% completed multi-filter endeavor?